-
Deaths from unexplained kidney disease rose to 178 in Indonesia
Time of Update: 2022-11-15
(End) Indonesian Health Minister Budi Gunadi Sadikin reported in Jakarta on the 2nd that the number of cases of unexplained kidney disease reported in the country has increased to 325, of which 178 deaths.
-
When CDMO steps out of real estate
Time of Update: 2022-10-25
Although the boom in innovative drug research and development has cooled rapidly within a year, capacity building and commercial production is a long process, and the large amount of demand accumulated before will not disappear in a short time.
-
Chinese scholars have made new progress in the field of tumor immunotherapy
Time of Update: 2022-10-20
Figure Tumor drainage of TdLN-TTSM cells differentiated in lymph nodes into the tumor microenvironment to play a role With the support of the National Natural Science Foundation of China (approval nu
-
Researchers at the Institute of Microbiology have discovered a new model of cell behavior regulation of iatrogenic pathogenic bacteria
Time of Update: 2022-09-21
01414-22 Wang Fangfang's team from the Qianwei Group of the Institute of Microbiology published a research paper titled Dual regulatory role exerted by cyclic dimeric GMP to control FsnR-mediated bacterial swimming on September 7 at mBio. Stenotrophomonas maltophilia is an iatrogenic condition pathogenic bacterium that has seriously threatened people's lives and health in recent years, with high detection rates in ICU wards, high fatality rates, and multiple drug resistance.
-
Daewoong Pharmaceutical Announces U.S. FDA Approval of its IND Application for DWP213388, the First-in-Class Oral, Irreversible, Dual-Acting Antifungal Drug for the Treatment of Autoimmune Diseases
Time of Update: 2022-08-20
, Ltd —DWP213388 is the first-in-class dual-target inhibitor that simultaneously inhibits pathogenic T cells and B cells in various autoimmune diseases SEOUL, South Korea, Aug. 15, 2022 /PRNewswire/ -- Daewoong Pharmaceutical, a publicly listed South Korean company that develops, manufactures and sells pharmaceuticals globally, announced today that the company's Investigational New Drug (IND) application has been approved in the U.
-
Public comments on the check points for drug marketing authorization holders
Time of Update: 2022-05-25
Recently, the State Food and Drug Administration issued the "Check Points for Drug Marketing Authorization Holders (Draft for Comment)" (hereinafter referred to as the "Draft for Comment") . Accord
-
"The 14th Five-Year Plan for the Development of Market Supervision Technology" is issued: Cultivating State Key Laboratories to Effectively Standardize Inspection and Testing
Time of Update: 2022-04-30
The "Plan" also proposes that in strengthening the capacity building of service industry upgrading and promoting high-end development, it is necessary to actively explore the construction of national-level quality standard laboratories, so as to promote the advanced industrial foundation and the modernization of industrial chains and supply chains to provide strategic and reserve resources.
-
BIPS 2nd Global Biomedical Innovation Pioneer China Summit 2022
Time of Update: 2022-04-16
·The summit includes two parallel forums, namely, the Pioneer Forum of Biomedical R&D Innovation and the Pioneer Forum of Biopharmaceutical Process Innovation .
-
Two metal ion-dependent enzymes as potential antiviral targets for human herpesviruses
Time of Update: 2022-02-17
SummaryMost drug development efforts targeting herpes viruses have focused on nucleoside analogs targeting viral DNA polymerases that have been associated with dose-limiting toxicity and/or narrow-spectrum activity .
-
Ren Wenkai/Professor Peng Yuanyi's teamwork revealed that melatonin targets type II citrate synthase to inhibit Gram-negative bacteria
Time of Update: 2022-01-26
Recently, Professor Ren Wenkai's research group from South China Agricultural University, Professor Peng Yuanyi's research group from Southwest University and Professor Liu Yuan's research group from Yangzhou University School of Veterinary Medicine jointly published a research titled "Melatonin inhibits Gram-negative pathogens by targeting citrate synthase" in Science China Life Sciences The paper reveals the antibacterial target and mechanism of melatonin-specific inhibition of Gram-negative bacteria .
-
Longquan Shao's team has made new progress in the field of nanomedicine
Time of Update: 2021-12-29
The latest research results "Nano-graphene oxide depresses neurotransmission by blocking retrograde transport of mitochondria" were published in the Journal of Hazardous Materials, the TOP journal in the field of environmental sciences.
-
New drug for hyperkalemia
Time of Update: 2021-12-02
S. Food and Drug Administration (FDA) has granted the new oral potassium-lowering drug Lokelma (Liberzol®, generic name: sodium zirconium cyclosilicate, sodium zirconium cyclosilicate) fast track qualification ( FTD): Used for patients with recurrent hyperkalemia (HK) undergoing chronic dialysis to reduce cardiovascular outcomes related to arrhythmia .
-
A breakthrough in Yangtze River's proprietary Chinese medicines
Time of Update: 2021-11-04
Figure 1: New drugs declared by Yangtze River since 2021Source: CDE official websiteFigure 2: Clinical progress of new drugsSource: China Drug Clinical Trial Publicity Library of MeinenetSince the beginning of this year, Yangtze River has applied for clinical application of 3 new drugs: the indication is analgesic chemical medicine Class 1 new drug YR-1702 injection and the indication is seasonal allergic rhinitis Chinese medicine Class 2.
-
Nature: Stanford research team achieved non-invasive early lung cancer screening
Time of Update: 2021-10-01
The method is based on the detection of tumor-derived DNA in blood samples (liquid biopsy), which means that screening of people at high risk of lung cancer is early and non-invasive .
-
The brain will also "one area with two purposes". The neurons that control habit also learn new behaviors
Time of Update: 2021-09-18
The test results showed that after only one training session, neurons in a specific area of the striatum of the experimental group were significantly more active than those in the control group, indicating that they played a role in learning .
